Last reviewed · How we verify

NCT06243016: HIIT2SITLess

Breaking Sitting with High-intensity Interval Training for Brain Health

Recruiting now NA Last updated 7 February 2025
What this trial tests

NA trial testing High-Intensity Interval Training (HIIT) Breaks to Sitting in Aging in 54 participants. Currently enrolling.

Timeline
7 May 2024
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorUniversity of Illinois at Urbana-Champaign
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment54
Start date7 May 2024
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 40 to 75, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT breaks to sitting. It will also address several important but unanswered questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Breaking prolonged sitting with high-intensity interval training to improve cognitive and brain health in middle-aged and older adults: a protocol for the pilot feasibility HIIT2SITLess trial.
    Pindus DM, Paluska S, So J, Wyczesany M, et al · · 2025 · PMID 40341152 · DOI 10.1136/bmjopen-2024-095415

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06243016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing